
Keywords: NODAT; new onset diabetes after transplantation; IAs; immunosuppressive agents; BAT; brown adipose tissue; Akt; protein kinase B; mTOR; mammalian target of rapamycin; GLUT4; glucose transporter 4; IRS; insulin receptor substrate; JNK; N-terminal Janus act